8FINK F M, KOLLER V, MAYER H, et al. Prognosfie Significance of myeloid-asseiated artigen expression on blast cells in children with caufe lymphoblasfie leukemia [J]. Med Peeliater Med Pdiater Oneol, 1993, 21: 340- 346.
9PUIC H, SCHELL M J, RAIMOUDI S C, et al. Myeloid-antigen expression in childhood acute lymphoblasfic leukemin[J]. N Engl Jmed, 1991,325: 1378- 1379.
2[1]Weir EG, Borowitz MJ. Flow cytometry in the diagnosis of acute leukemia. Semin Hematol, 2001; 38: 124-138
3[2]Huh YO, Ibrahim S. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am, 2000; 14:1251-1265
4[3]Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood, 1997; 90:2863-2892
5[4]Khalidi HS, Chang KL, Medeiros LJ, et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol, 1999; 111:467-476
6[5]Hann IM, Richards SM, Eden OB, et al. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party. Leukemia, 1998; 12:1249-1255
7[6]Guglielmi C, Cordone I, Boecklin F, et al. Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications. Leukemia, 1997; 11:1501-1507
8[7]Ciudad J, Orfao A, Vidriales B, et al. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica, 1998; 83:1069-1075
9[8]Loken MR, Wells DA. Normal antigen expression in hematopoiesis. Edited by Stewart CC, Nicholson JKA. Immunophenotyping. WILEY-LISS, Inc. 2000: 215-238
10[9]Lucio P, Parreira A, Van-den Beemd MW, et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia, 1999; 13:419-427
